Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipid-Based Nanocarriers via Nose-to-Brain Pathway for Central Nervous System Disorders
Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Tran Nguyen Minh An, et al.
Neurochemical Research (2021) Vol. 47, Iss. 3, pp. 552-573
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Recent Advances in Intranasal Administration for Brain-Targeting Delivery: A Comprehensive Review of Lipid-Based Nanoparticles and Stimuli-Responsive Gel Formulations
Jain Koo, Chaemin Lim, Kyung Taek Oh
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 1767-1807
Open Access | Times Cited: 24
Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport
Shivani Gandhi, Divyesh H. Shastri, Jigar Shah, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 481-481
Open Access | Times Cited: 20
Nanostructured lipid carrier system: A compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications in drug delivery
Shamama Javed, Bharti Mangla, Yosif Almoshari, et al.
Nanotechnology Reviews (2022) Vol. 11, Iss. 1, pp. 1744-1777
Open Access | Times Cited: 46
Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date
Bwalya A. Witika, Madan Poka, Patrick H. Demana, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 836-836
Open Access | Times Cited: 45
siRNA‐based nanotherapeutics as emerging modalities for immune‐mediated diseases: A preliminary review
Saman Sargazi, Rabia Arshad, Reza Ghamari, et al.
Cell Biology International (2022) Vol. 46, Iss. 9, pp. 1320-1344
Open Access | Times Cited: 42
Intranasal Drug Administration in Alzheimer-Type Dementia: Towards Clinical Applications
Raquel Taléns‐Visconti, Jesús Vicente de Julián-Ortiz, Ofelia Vila-Busó, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1399-1399
Open Access | Times Cited: 27
How Precise are Nanomedicines in Overcoming the Blood–Brain Barrier? A Comprehensive Review of the Literature
Priyadarshini Mohapatra, Mohanraj Gopikrishnan, C. George Priya Doss, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2441-2467
Open Access | Times Cited: 13
Lipid and Transcriptional Regulation in a Parkinson's Disease Mouse Model by Intranasal Vesicular and Hexosomal Plasmalogen‐Based Nanomedicines
Yu Wu, Jieli Wang, Yuru Deng, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 14
Open Access | Times Cited: 8
MicroRNAs in Parkinson’s disease: From pathogenesis to diagnostics and therapeutic strategies
Dongying Zheng, Jibing Chween
Neuroscience (2025)
Closed Access | Times Cited: 1
A comprehensive insight of innovations and recent advancements in nanocarriers for nose-to-brain drug targeting
Naeem Mubarak, Muhammad Ahsan Waqar, Asad Majeed Khan, et al.
Designed Monomers & Polymers (2025) Vol. 28, Iss. 1, pp. 7-29
Open Access | Times Cited: 1
Cell membrane-based nanomaterials for therapeutics of neurodegenerative diseases
Phuong‐Trang Nguyen‐Thi, Thuy Trang Nguyen, Hoàng Long Phan, et al.
Neurochemistry International (2023) Vol. 170, pp. 105612-105612
Closed Access | Times Cited: 18
Lipid-based nanoparticles via nose-to-brain delivery: a mini review
Yang Xinchen, Jing Tan, Guan Jiaoqiong
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 17
An Overview on the Physiopathology of the Blood–Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery
Francesca Susa, Silvia Arpicco, Candido Fabrizio Pirri, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 849-849
Open Access | Times Cited: 6
Multiple CEST contrast imaging of nose-to-brain drug delivery using iohexol liposomes at 3T MRI
Lok Hin Law, Jianpan Huang, Peng Xiao, et al.
Journal of Controlled Release (2023) Vol. 354, pp. 208-220
Open Access | Times Cited: 15
Chitosan-coated nanostructured lipid carriers for effective brain delivery of Tanshinone IIA in Parkinson’s disease: interplay between nuclear factor-kappa β and cathepsin B
Donia M. Hassan, Amal H. El‐Kamel, Eman Allam, et al.
Drug Delivery and Translational Research (2023) Vol. 14, Iss. 2, pp. 400-417
Open Access | Times Cited: 15
Current strategies of detecting Aβ species and inhibiting Aβ aggregation: Status and prospects
Jun Li, Wang Liao, Dongqing Huang, et al.
Coordination Chemistry Reviews (2023) Vol. 495, pp. 215375-215375
Closed Access | Times Cited: 13
Recent Advances in the Development of Liquid Crystalline Nanoparticles as Drug Delivery Systems
Jassica S. L. Leu, Jasy J. X. Teoh, Angel L. Q. Ling, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1421-1421
Open Access | Times Cited: 12
Brain distribution study of [14C]-Riluzole following intranasal administration in mice
Rafal S Baker, Julie Wang, Nadia Rouatbi, et al.
International Journal of Pharmaceutics (2025) Vol. 670, pp. 125195-125195
Open Access
Efficient nose-to-brain delivery of nine residues peptide (JAL-TA9) exhibiting hydrolytic activity against amyloid-β
Yusuke Hatakawa, Akiko Tanaka, Tomoyuki Furubayashi, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2025), pp. 114661-114661
Closed Access
Lipid-Based Nanoparticles for Neurological Drug Discovery
Chandran Sathya, S. Natarajan, Bhagavathi Sundaram Sivamaruthi
Nanotechnology in the life sciences (2025), pp. 283-301
Closed Access
Thermosensitive, mucoadhesive brivaracetam nasal gel: a promising strategy for targeted relief of epilepsy
Birinder Narang, Kalyani Barve, Sarika Wairkar
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Review on novel targeted enzyme drug delivery systems: enzymosomes
Dinesh Kumar, Komal Sachdeva, Rajni Tanwar, et al.
Soft Matter (2024) Vol. 20, Iss. 23, pp. 4524-4543
Closed Access | Times Cited: 3
Nanomedicine in Neuroprotection, Neuroregeneration, and Blood–Brain Barrier Modulation: A Narrative Review
Antea Kršek, Ana Jagodic, Lara Batičić
Medicina (2024) Vol. 60, Iss. 9, pp. 1384-1384
Open Access | Times Cited: 3
Innovation in nanomedicine: nanocarriers for central nervous system disorders management
Muhammad Ahsan Waqar, Naeem Mubarak, Asad Majeed Khan, et al.
International Journal of Polymeric Materials (2024), pp. 1-18
Closed Access | Times Cited: 3
Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders
Thuy Trang Nguyen, Phuong‐Trang Nguyen‐Thi, Thi Hong Anh Nguyen, et al.
Molecular Diagnosis & Therapy (2023) Vol. 27, Iss. 4, pp. 457-473
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top